While these genes have been previously associated with prostate cancer [31,32], this is the first comparative functional screening of the GPCR knockdown phenotypes in different cultured prostate cell lines, combined with the bioinformatic analysis of their relative expression levels in prostate tumor samples. This evidence concerns the gene FZD4 and prostate carcinoma.